This HTML5 document contains 46 embedded RDF statements represented using HTML+Microdata notation.

The embedded RDF content will be recognized by any processor of HTML5 Microdata.

Namespace Prefixes

PrefixIRI
n2http://linked.opendata.cz/resource/drugbank/drug/
dctermshttp://purl.org/dc/terms/
n9http://linked.opendata.cz/resource/drugbank/drug/DB08795/identifier/drugbank/
n11http://bio2rdf.org/drugbank:
admshttp://www.w3.org/ns/adms#
n4http://wifo5-03.informatik.uni-mannheim.de/drugbank/resource/drugs/
rdfhttp://www.w3.org/1999/02/22-rdf-syntax-ns#
n6http://linked.opendata.cz/ontology/drugbank/
n15http://linked.opendata.cz/resource/drugbank/drug/DB08795/identifier/chebi/
owlhttp://www.w3.org/2002/07/owl#
n7http://linked.opendata.cz/resource/drugbank/property/
xsdhhttp://www.w3.org/2001/XMLSchema#
n12http://linked.opendata.cz/resource/drugbank/drug/DB08795/identifier/wikipedia/
n10http://linked.opendata.cz/resource/drugbank/drug/DB08795/identifier/pharmgkb/
n14http://linked.opendata.cz/resource/atc/
n13http://linked.opendata.cz/ontology/sukl/drug/

Statements

Subject Item
n2:DB08795
rdf:type
n6:Drug
n6:description
Azidocillin is a penicillin antibiotic similir to ampicillin.
n6:group
approved
n6:indication
For treatment of infection (Respiratory, GI, UTI and meningitis) due to E. coli, P. mirabilis, enterococci, Shigella, S. typhosa and other Salmonella, nonpenicillinase-producing N. gononhoeae, H. influenzae, staphylococci, streptococci including streptoc
owl:sameAs
n4:DB08795 n11:DB08795
dcterms:title
Azidocillin
adms:identifier
n9:DB08795 n10:PA165958414 n12:Azidocillin n15:51758
n6:mechanismOfAction
By binding to specific penicillin-binding proteins (PBPs) located inside the bacterial cell wall, Azidocillin inhibits the third and last stage of bacterial cell wall synthesis. Cell lysis is then mediated by bacterial cell wall autolytic enzymes such as autolysins; it is possible that Azidocillin interferes with an autolysin inhibitor.
n6:synonym
Azidocilina Azidocilline D-(-)-(alpha-Azidobenzyl)penicillin Azidocillinum (2S,5R,6R)-6-{[(2R)-2-azido-2-phenylacetyl]amino}-3,3-dimethyl-7-oxo-4-thia-1-azabicyclo[3.2.0]heptane-2-carboxylic acid
n6:IUPAC-Name
n7:271B54A4-363D-11E5-9242-09173F13E4C5
n6:InChI
n7:271B54AA-363D-11E5-9242-09173F13E4C5
n6:Molecular-Formula
n7:271B54A9-363D-11E5-9242-09173F13E4C5
n6:Molecular-Weight
n7:271B54A6-363D-11E5-9242-09173F13E4C5
n6:Monoisotopic-Weight
n7:271B54A7-363D-11E5-9242-09173F13E4C5
n6:SMILES
n7:271B54A8-363D-11E5-9242-09173F13E4C5
n6:Water-Solubility
n7:271B54A2-363D-11E5-9242-09173F13E4C5
n6:logP
n7:271B54A3-363D-11E5-9242-09173F13E4C5 n7:271B54A0-363D-11E5-9242-09173F13E4C5
n6:logS
n7:271B54A1-363D-11E5-9242-09173F13E4C5
n13:hasATCCode
n14:J01CE04
n6:H-Bond-Acceptor-Count
n7:271B54B0-363D-11E5-9242-09173F13E4C5
n6:H-Bond-Donor-Count
n7:271B54B1-363D-11E5-9242-09173F13E4C5
n6:InChIKey
n7:271B54AB-363D-11E5-9242-09173F13E4C5
n6:Polar-Surface-Area--PSA-
n7:271B54AC-363D-11E5-9242-09173F13E4C5
n6:Polarizability
n7:271B54AE-363D-11E5-9242-09173F13E4C5
n6:Refractivity
n7:271B54AD-363D-11E5-9242-09173F13E4C5
n6:Rotatable-Bond-Count
n7:271B54AF-363D-11E5-9242-09173F13E4C5
n6:casRegistryNumber
17243-38-8
n6:category
n6:Bioavailability
n7:271B54B6-363D-11E5-9242-09173F13E4C5
n6:Ghose-Filter
n7:271B54B8-363D-11E5-9242-09173F13E4C5
n6:MDDR-Like-Rule
n7:271B54B9-363D-11E5-9242-09173F13E4C5
n6:Number-of-Rings
n7:271B54B5-363D-11E5-9242-09173F13E4C5
n6:Physiological-Charge
n7:271B54B4-363D-11E5-9242-09173F13E4C5
n6:Rule-of-Five
n7:271B54B7-363D-11E5-9242-09173F13E4C5
n6:Traditional-IUPAC-Name
n7:271B54A5-363D-11E5-9242-09173F13E4C5
n6:pKa--strongest-acidic-
n7:271B54B2-363D-11E5-9242-09173F13E4C5
n6:pKa--strongest-basic-
n7:271B54B3-363D-11E5-9242-09173F13E4C5